These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4673601)

  • 21. [STUDY OF THE EPIDEMIOLOGICAL EFFECTIVENESS OF PURIFIED SORBED SCARLET FEVER TOXIN].
    MITELMAN SL
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Sep; 40():61-4. PubMed ID: 14119969
    [No Abstract]   [Full Text] [Related]  

  • 22. Micro complement fixation assay for type-specific group A streptococcal antibody.
    Wittner MK; Fox EN
    Infect Immun; 1971 Oct; 4(4):441-5. PubMed ID: 5005302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dick test results: 1969-1971.
    Quinn RW
    J Infect Dis; 1972 Aug; 126(2):136-42. PubMed ID: 5053898
    [No Abstract]   [Full Text] [Related]  

  • 24. Diphtheria as a model. Introduction of serums and vaccines for scarlet fever and pneumococcal pneumonia.
    Dowling HF
    JAMA; 1973 Oct; 226(5):550-3. PubMed ID: 4147662
    [No Abstract]   [Full Text] [Related]  

  • 25. Determination of anti group A streptococcal polysaccharide antibodies in human sera by an hemagglutination technique.
    Goldstein I; Caravano R
    Proc Soc Exp Biol Med; 1967 Apr; 124(4):1209-12. PubMed ID: 6024836
    [No Abstract]   [Full Text] [Related]  

  • 26. [A method for the quantitative estimation of antibodies to extracellular esterases produced by group A and B streptococci, and application to the sera of patients with scarlet fever (author's transl)].
    Hayano S; Tanaka A
    Kansenshogaku Zasshi; 1981 May; 55(5):339-45. PubMed ID: 6798138
    [No Abstract]   [Full Text] [Related]  

  • 27. Study of the MAP antibodies in the human streptococcal infections.
    Mihalcu F
    Arch Roum Pathol Exp Microbiol; 1979; 38(1):25-32. PubMed ID: 546370
    [No Abstract]   [Full Text] [Related]  

  • 28. [Scarlet fever in childhood--1969].
    Ocklitz HW; Padelt H
    Zentralbl Bakteriol Orig; 1970; 214(3):428-39. PubMed ID: 5534040
    [No Abstract]   [Full Text] [Related]  

  • 29. [Changes in antistreptococcal antibodies in scarlet fever].
    Hamd SS; Guasco C
    G Mal Infett Parassit; 1967 Jun; 19(6):382-6. PubMed ID: 6051990
    [No Abstract]   [Full Text] [Related]  

  • 30. [Characteristics of antitoxin immunity in scarlet fever].
    Fiks LI; Bliumental' KV; Silich VA; Dodonov VN; Sezonova EP
    Pediatriia; 1972 Feb; 51(2):44-8. PubMed ID: 5036295
    [No Abstract]   [Full Text] [Related]  

  • 31. [Mitogenic activity of erythrogenic toxins. I. Type-specific inhibition of the mitogenic activity of erythrogenic toxins by antitoxic antisera from the rabbit (author's transl)].
    Petermann F; Knöll H; Köhler W
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(3):366-79. PubMed ID: 352038
    [No Abstract]   [Full Text] [Related]  

  • 32. [Relationship between anti-streptokinase levels and hemolytic streptococcal types in scarlet fever].
    Shimizu H; Iimura T; Yagishita N; Nagase K
    Kansenshogaku Zasshi; 1973 Dec; 47(12):522-3. PubMed ID: 4208601
    [No Abstract]   [Full Text] [Related]  

  • 33. Modern trends in the treatment of scarlet fever.
    McLACHLAN IM
    Med Press; 1951 Feb; 225(7):147-50. PubMed ID: 14805669
    [No Abstract]   [Full Text] [Related]  

  • 34. PROPERTIES OF TOXOPLASMA LYSATES TOXIC TO RABBITS ON INTRAVENOUS INJECTION.
    LUNDE MN; JACOBS L
    J Parasitol; 1964 Feb; 50():49-51. PubMed ID: 14125168
    [No Abstract]   [Full Text] [Related]  

  • 35. [Erythrocyte agglutination method in immunological studies in scarlet fever].
    MOLNAR A; NARAI S; FOLDES J
    Gyermekgyogyaszat; 1956; 7(5-6):178-80. PubMed ID: 13345123
    [No Abstract]   [Full Text] [Related]  

  • 36. [Serological study on scarlet fever].
    Nakamizo Y; Tsuji S; Shimizu H
    Kansenshogaku Zasshi; 1973 Dec; 47(12):519-21. PubMed ID: 4208600
    [No Abstract]   [Full Text] [Related]  

  • 37. [Detection of scarlet fever antitoxin in the human serum with the aid of precipitation reaction].
    BACKHAUSZ R; KAMARAS J; OSZTOVICS M
    Gyermekgyogyaszat; 1954 Jan; 5(1):21-6. PubMed ID: 13151489
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cellular immune skin response in streptococcal infections].
    Mihalcu F; Stefănescu M; Plătică C; Mijá T; Marţian I; Roman E
    Arch Roum Pathol Exp Microbiol; 1973 Jun; 32(2):227-35. PubMed ID: 4750230
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of passive hemagglutination reaction for detection of antibodies to the L forms of Streptococcus].
    Chumachenko NV; Goncharova SA
    Lab Delo; 1973; 11():681-3. PubMed ID: 4132575
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinico-immunological aspects of scarlet fever today].
    Timofeeva GA; Ostrovskiĭ AD; Antipova LA; Eronina MF
    Pediatriia; 1984 Mar; (3):10-4. PubMed ID: 6609342
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.